Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last: $ 6.62 ◊ 0.00 (0.00%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Catalyst Pharmaceuticals Inc | CPRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.05 | 0.76% | 6.62 | 6.72 | 6.48 | 6.56 | 6.57 | 20:00:00 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 6.62 | 6.88 | 0.26 | 3.78% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 12,309 | 6,124,279 | $ 6.58 | $ 40,300,338 | 2,401,995 | 1.85 - 7.67 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:53:58 | 2 | $ 6.65 | USD |
Catalyst Pharmaceuticals Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 681.39M | 102.93M | $ -34.00M | -0.34 | -4,780.02 | 93.76M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Catalyst Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CPRX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 6.63 | 7.16 | 6 | 6.3486 | 3M | -0.01 | -0.15% |
| 1 Month | 6.26 | 7.67 | 5.65 | 6.3708 | 2M | 0.36 | 5.75% |
| 3 Months | 3.71 | 7.67 | 3.71 | 5.6205 | 2M | 2.91 | 78.44% |
| 6 Months | 3.57 | 7.67 | 2.235 | 4.6428 | 2M | 3.05 | 85.43% |
| 1 Year | 3.05 | 7.67 | 1.85 | 3.9132 | 2M | 3.57 | 117.05% |
| 3 Years | 1.04 | 7.67 | 0.9414 | 3.2584 | 1M | 5.58 | 536.54% |
| 5 Years | 3.08 | 7.67 | 0.51 | 3.0374 | 1M | 3.54 | 114.94% |
Catalyst Pharmaceuticals Description
| Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with lambert-eaton myasthenic syndrome. |
